Clinical Trial

A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS

Study acronym: THRIVE
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 27, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
Multi-center post-market, observational study to assess the long-term effectiveness and safety of the NTX100 TOMAC System for patients with Restless Legs Syndrome.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-10-06; most recent amendment 2026-05-22.
Status change: Recruiting → Active, Not Recruiting 2025-07-21
Trial Details
NCT Number NCT06076499
Lead Sponsor Noctrix Health, Inc.
Conditions Restless Legs Syndrome
Enrollment 325 participants
Start Date 2023-11-15
Primary Completion 2026-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-27